8.71M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019.

Similar securities

Based on sector and market capitalization

Report issue